arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Tenon Medical, Inc.

TNON

$3.30 ▼ -0.14 (-4.07%) at close

23 Visible periods

24 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Tenon Medical, Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap —

Dividend Yield —

Revenue Growth 126.8% ↗

Op. Margin -262.2% ↘

ROIC 152.0% ↗

FCF / Share —

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

23-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.28M

↑ +126.8% —

Net Income Profit after all expenses

$-4.05M

↓ -46.3% —

Operating Margin Operating profit as % of sales

-262.2%

↓ -10.3% 0th

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Revenue Growth YoY (%)	126.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1485%)	89.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1024%)	92.3% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1054%)	32.2% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+303%)	-37.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-568%)	1.0% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-88%)	-4.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-159%)	-6.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-175%)	21.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+166%)	66.1% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+726%)	191.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2296%)	353.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4323%)	450.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5530%)	509.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+6273%)	422.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5183%)	197.1% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2364%)	513.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+6320%)	373.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4567%)	—	—	—	—	—
EPS Growth YoY (%)	-3330.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	69.3% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	89.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	64.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	19.2% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	-148.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-209.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-190.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	29.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-421.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	49.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	—	-160.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	89.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	67.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	-46.3% Weak ↓ Weak Declining Year-over-year change in net income	3.9% Caution ↓ Caution Declining Year-over-year change in net income	8.3% Fair ↑ Fair Improving Year-over-year change in net income	-4.9% Weak ↓ Weak Declining Year-over-year change in net income	27.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-1.1% Weak ↓ Weak Declining Year-over-year change in net income	1.5% Caution ↓ Caution Declining Year-over-year change in net income	4.4% Caution ↓ Caution Declining Year-over-year change in net income	10.7% Fair ↓ Fair Declining Year-over-year change in net income	26.0% Excellent → Excellent Stable Year-over-year change in net income	60.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-5.1% Weak ↑ Weak Improving Year-over-year change in net income	21.9% Good ↑ Good Improving Year-over-year change in net income	-105.3% Weak ↑ Weak Improving Year-over-year change in net income	-178.1% Weak ↑ Weak Improving Year-over-year change in net income	-35.5% Weak ↑ Weak Improving Year-over-year change in net income	-229.6% Weak Weak Year-over-year change in net income	-1076.5% Weak Weak Year-over-year change in net income	—	—	—	—	—
Revenue CAGR 3Y (%)	19.8% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	47.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	74.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	78.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	61.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	117.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	144.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	133.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	244.7% Excellent Excellent Compound annual revenue growth over 3 years	263.3% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	125.4% Excellent Excellent Compound annual revenue growth over 5 years	147.0% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Operating Margin (%) (%)	-262.2% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1848%)	-237.9% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1686%)	-193.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1390%)	-289.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2028%)	—	—	-412.1% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2847%)	-362.5% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2516%)	-429.7% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2965%)	-487.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3351%)	-388.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2692%)	-357.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2486%)	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-316.7% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2739%)	-252.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2201%)	-191.2% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1694%)	-284.7% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2472%)	-491.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4191%)	-498.1% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4251%)	-400.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3441%)	-359.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3091%)	-424.6% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3639%)	-497.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4245%)	-387.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3332%)	-353.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3041%)	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	-229.1% Weak → Weak Stable Free cash flow as a percentage of revenue Optimal: > 10%	-218.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-163.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-335.5% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	—	-342.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-365.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-325.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-293.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.72x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.18x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.69x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.65x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.76x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.43x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.10x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.61x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Return on Invested Capital (%)	152.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-136.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-44.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-55.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-33.6% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-31.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-42.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-31.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-367.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-76.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-318.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-106.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-378.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-156.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-100.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-19.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	7.2% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	9.8% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	28.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	30.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	5.5% Caution Caution Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-33.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-25.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-26.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-32.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-25.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-27.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-32.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-24.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-64.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-43.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-49.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-46.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-43.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-64.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-71.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-30.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-29.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-27.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	232.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1449%)	-183.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1323%)	-56.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-475%)	-69.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-564%)	-41.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-375%)	-38.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-357%)	-51.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-445%)	-38.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-359%)	—	-98.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-758%)	—	-132.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-983%)	—	-195.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1402%)	-126.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-943%)	-24.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-263%)	-36.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-342%)	10.3% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-31%)	13.8% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-8%)	39.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+163%)	40.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+168%)	7.4% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-51%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	-103.12x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-844.50x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-991.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-62.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-7.59x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-9.12x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-7.85x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-26.02x Weak Weak Operating income divided by interest expense Optimal: > 5x	-17.18x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-1.68M	$-4.61M	$-3.76M	$-3.44M	$-7.85M	$-10.31M	$-6.54M	$-9.16M	$-1.97M	$-4.39M	$-2.43M	$-3.37M	$-5.85M	$-3.18M	$-2.13M	$-3.15M	$-7.88M	$-4.68M	$-2.92M	—	—	—	—

📊 What does each share earn? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Basic EPS, GAAP (USD)	$-12.35	$-0.31	$-0.22	$-0.40	$-0.36	$-1.01	$7.34	$-3.63	$-1.02	$-1.25	$-5.46	$-1.46	$-0.33	$-0.43	$-7.71	$-0.28	$-0.65	—	$-2.96	$-2.55	$-2.01	—	—
Book Value per Share (USD)	$-5.27	$0.17	$0.46	$0.56	$0.88	$1.24	$1.90	$2.61	$0.22	$0.97	$2.39	$1.02	$0.04	$0.22	$5.56	$1.15	$1.34	$-22.97	$-20.76	—	—	—	—
Tangible Book Value per Share (USD)	$-13.93	$-0.09	$0.20	$0.22	$0.88	$1.24	$1.90	$2.61	$0.22	$0.97	$2.39	$1.02	$0.04	$0.22	$5.56	$1.15	$1.34	$-22.97	$-20.76	—	—	—	—
Basic Weighted Avg Shares (shares)	328	11,268	—	8,250	7,591	3,597	—	877	3,749	2,853	—	2,276	13,051	11,242	—	11,237	8,422	—	—	919	830	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Working Capital (USD)	$-3.50M	$215.00K	$3.56M	$3.50M	$7.32M	$9.79M	$6.34M	$8.01M	$684.00K	$3.69M	$749.00K	$1.88M	$1.06M	$3.09M	$6.82M	$12.40M	$14.62M	$-9.98M	$-7.60M	—	—	—	—
Total Equity (USD)	$-1.74M	$1.90M	$5.04M	$4.80M	$6.71M	$9.38M	$5.97M	$8.19M	$832.00K	$3.62M	$778.00K	$2.52M	$903.00K	$2.47M	$6.25M	$12.95M	$15.11M	$-22.74M	$-20.55M	$-5.92M	$-4.14M	$-2.71M	$-2.71M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Sales/Revenue/Turnover (USD)	$1.28M	$1.38M	$1.48M	$1.17M	$564.00K	$726.00K	$770.00K	$887.00K	$901.00K	$719.00K	$808.00K	$944.00K	$743.00K	$433.00K	$277.00K	$208.00K	$135.00K	$71.00K	$53.00K	$70.00K	$22.00K	$15.00K	—
Depreciation Expense (USD)	$45.00K	$73.00K	$80.00K	$68.00K	$48.00K	$42.00K	$117.00K	$102.00K	$89.00K	$100.00K	$87.00K	$46.00K	$35.00K	$25.00K	$25.00K	$24.00K	$19.00K	$10.00K	$1.00K	$1.00K	$0.00	$0.00	—
Net Income, GAAP (USD)	$-4.05M	$-3.48M	$-2.83M	$-3.34M	$-2.77M	$-3.62M	$-3.09M	$-3.18M	$-3.83M	$-3.58M	$-3.13M	$-3.33M	$-4.29M	$-4.83M	$-7.91M	$-3.17M	$-5.49M	$-2.35M	$-2.84M	$-2.34M	$-1.67M	$-200.00K	—
Operating Cash Flow (USD)	$-2.76M	$-2.96M	$-2.22M	$-3.82M	—	$-2.48M	$-2.78M	—	—	$-2.34M	$-2.28M	—	—	$-3.58M	$-3.38M	—	—	$-2.46M	$-1.69M	$-1.41M	$-1.03M	$-162.00K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 6 years · 23 quarters

Tenon Medical, Inc.

Analytical Summary

23-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare TNON with peers